MorphoSys AG (NASDAQ:MOR)
| 4.91 Delayed Data As of Jan 26 |  +0.04 / +0.82%Today’s Change | 3.17 Today|||52-Week Range 8.26 | +37.15% Year-to-Date |
Latest MOR News | Press Releases
No recent news for MorphoSys AG.
Today’s Trading
| Previous close | 4.89 |
| Today’s open | 4.94 |
| Day’s range | 4.85 - 4.97 |
| Volume | 32,792 |
| Average volume (3 months) | 149,445 |
| Market cap | $631.2M |
Data as of 3:59pm ET, 01/26/2023
Growth & Valuation
| Earnings growth (last year) | -630.65% |
| Earnings growth (this year) | +31.36% |
| Earnings growth (next 5 years) | -21.25% |
| Revenue growth (last year) | -43.17% |
| P/E ratio | NM |
| Price/Sales | 5.93 |
| Price/Book | 2.26 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EBSEmergent BioSolution... | -0.34 | -2.53% |
| MCRBSeres Therapeutics I... | +0.08 | +1.57% |
| CHRSCoherus BioSciences ... | -0.44 | -5.01% |
| MRSNMersana Therapeutics... | -0.09 | -1.37% |
Data as of 4:00pm ET, 01/26/2023
Financials
| Next reporting date | March 16, 2023 |
| EPS forecast (this quarter) | $0.09 |
| Annual revenue (last year) | $212.3M |
| Annual profit (last year) | -$608.1M |
| Net profit margin | -286.43% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Planegg, Bayern (bavaria) |
Forecasts
